BR0312446A - 2-heteroaril carboxamidas - Google Patents

2-heteroaril carboxamidas

Info

Publication number
BR0312446A
BR0312446A BR0312446-0A BR0312446A BR0312446A BR 0312446 A BR0312446 A BR 0312446A BR 0312446 A BR0312446 A BR 0312446A BR 0312446 A BR0312446 A BR 0312446A
Authority
BR
Brazil
Prior art keywords
heteroaryl carboxamides
carboxamides
heteroaryl
prophylaxis
learning
Prior art date
Application number
BR0312446-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Joachim Luithle
Frank-Gerhard B Ss
Christina Erb
Frank-Thorsten Hafner
Katrin Schnizler
Timo Flessner
Marja Van Kampen
Franz-Josef Van Der Staay
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10257078A external-priority patent/DE10257078A1/de
Priority claimed from DE2002157537 external-priority patent/DE10257537A1/de
Priority claimed from DE10305922A external-priority patent/DE10305922A1/de
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BR0312446A publication Critical patent/BR0312446A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
BR0312446-0A 2002-06-10 2003-06-02 2-heteroaril carboxamidas BR0312446A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10225536 2002-06-10
DE10257078A DE10257078A1 (de) 2002-12-06 2002-12-06 2-Heteroarylcarbonsäureamide
DE2002157537 DE10257537A1 (de) 2002-12-10 2002-12-10 2-Heteroarylcarbonsäureamide
DE10305922A DE10305922A1 (de) 2002-06-10 2003-02-13 2-Heteroarylcarbonsäureamide
PCT/EP2003/005735 WO2003104227A1 (de) 2002-01-20 2003-06-02 2-heteroarylcarbonsäureamide

Publications (1)

Publication Number Publication Date
BR0312446A true BR0312446A (pt) 2005-04-19

Family

ID=29740887

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312446-0A BR0312446A (pt) 2002-06-10 2003-06-02 2-heteroaril carboxamidas

Country Status (16)

Country Link
US (5) US7977485B2 (enExample)
EP (1) EP1515967B1 (enExample)
JP (1) JP4542891B2 (enExample)
CN (1) CN1675204A (enExample)
AT (1) ATE344262T1 (enExample)
AU (1) AU2003238450A1 (enExample)
BR (1) BR0312446A (enExample)
CA (1) CA2488761C (enExample)
DE (1) DE50305587D1 (enExample)
ES (1) ES2276072T3 (enExample)
IL (1) IL165505A0 (enExample)
MX (1) MXPA04012439A (enExample)
NO (1) NO20050063L (enExample)
PL (1) PL374551A1 (enExample)
UY (1) UY27841A1 (enExample)
WO (1) WO2003104227A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
US7977485B2 (en) * 2002-06-10 2011-07-12 Bayer Schering Pharma Aktiengesellshaft 2-heteroaryl carboxamides
CA2499128C (en) * 2002-09-25 2012-07-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
DE602004031124D1 (de) 2003-08-13 2011-03-03 Neurosearch As Neue chinuklidinderivative und deren pharmazeutische verwendung
US7396833B2 (en) 2003-12-22 2008-07-08 Memory Pharmaceuticals Corporation Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
CN103724343A (zh) 2004-03-25 2014-04-16 记忆药物公司 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑及其制备和用途
JP2007538046A (ja) 2004-05-19 2007-12-27 ノイロサーチ アクティーゼルスカブ 新規なアザビシクロアリール誘導体
CN100588657C (zh) * 2004-10-15 2010-02-10 神经研究公司 新的氮杂双环芳基衍生物及其医药用途
US8106066B2 (en) * 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
RU2474581C2 (ru) * 2007-12-26 2013-02-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Способ получения замещенных гетероциклом производных пиридина
US8367676B2 (en) * 2009-06-30 2013-02-05 Astrazeneca Ab 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
CN103221411B (zh) 2010-05-17 2016-05-11 富瑞姆制药公司 (R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型
WO2012087229A1 (en) 2010-12-20 2012-06-28 Astrazeneca Ab 2-carboxamide-4-piperazinyl-benzofuran derivative
KR101928505B1 (ko) * 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
AU2013259871A1 (en) 2012-05-08 2014-11-20 Forum Pharmaceuticals Inc. Methods of maintaining, treating or improving cognitive function
CN111205283A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质b的合成方法
CN111205284A (zh) * 2020-01-20 2020-05-29 广州九植医药科技有限公司 一种盐酸帕洛诺司琼有关物质a的合成方法
US20230391758A1 (en) * 2020-09-18 2023-12-07 Merck Sharp & Dohme Llc Modified benzofuran-carboxamides as glucosylceramide synthase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
JP4616971B2 (ja) * 2000-07-18 2011-01-19 田辺三菱製薬株式会社 １−アザビシクロアルカン化合物およびその医薬用途
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
US6911543B2 (en) 2001-10-02 2005-06-28 Pfizer Inc. Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
US7977485B2 (en) * 2002-06-10 2011-07-12 Bayer Schering Pharma Aktiengesellshaft 2-heteroaryl carboxamides
DE10234424A1 (de) 2002-07-29 2004-02-12 Bayer Ag Benzothiophen-, Benzofuran- und Indolharnstoffe

Also Published As

Publication number Publication date
US9067931B2 (en) 2015-06-30
AU2003238450A1 (en) 2003-12-22
US20160122337A1 (en) 2016-05-05
CA2488761C (en) 2011-05-31
JP2005533052A (ja) 2005-11-04
CA2488761A1 (en) 2003-12-18
JP4542891B2 (ja) 2010-09-15
ATE344262T1 (de) 2006-11-15
MXPA04012439A (es) 2005-04-19
US20060160877A1 (en) 2006-07-20
NO20050063L (no) 2005-01-06
DE50305587D1 (en) 2006-12-14
US10214524B2 (en) 2019-02-26
EP1515967A1 (de) 2005-03-23
US7977485B2 (en) 2011-07-12
US20110263591A1 (en) 2011-10-27
UY27841A1 (es) 2003-12-31
WO2003104227A1 (de) 2003-12-18
ES2276072T3 (es) 2007-06-16
US20120258964A1 (en) 2012-10-11
PL374551A1 (en) 2005-10-31
US20140350008A1 (en) 2014-11-27
CN1675204A (zh) 2005-09-28
IL165505A0 (en) 2006-01-15
EP1515967B1 (de) 2006-11-02

Similar Documents

Publication Publication Date Title
BR0312446A (pt) 2-heteroaril carboxamidas
NL300933I2 (nl) Letermovir
DE50310516D1 (de) Fredericamycin-derivate
CY1110019T1 (el) Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
ATE453642T1 (de) Substituierte phenylaminopyrimidine
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
WO2003078431A8 (de) Aza- bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
MA28613B1 (fr) Macrocycles d'amide antibacteriens
ATE338036T1 (de) Zur behandlung hyperproliferativer erkrankungen geeignete benzofuran- und benzothiophenderivate
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
WO2003078430A8 (de) Essig- und propionsäureamide
UY28313A1 (es) Nonadepsipeptidos acilados
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
ECSP055844A (es) Nuevos compuestos triciclicos
EP1494696A4 (en) TREATMENT OF PULMONARY DISORDERS
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
NO20032406D0 (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE433459T1 (de) Desoxo-nonadepsipeptide
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
DE502004012196D1 (de) Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
DE60219495D1 (de) Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]